Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print Improved estrogen reception may sharpen fuzzy memory

Improved estrogen reception may sharpen fuzzy memory

July 30, 2008

GAINESVILLE, Fla. - Estrogen treatments may sharpen mental performance in women with certain medical conditions, but University of Florida researchers suggest that recharging a naturally occurring estrogen receptor in the brain may also clear cognitive cobwebs.

The discovery suggests that drugs can be developed to offset "senior moments" related to low estrogen levels, as well as to protect against neurological diseases, all while avoiding the problems associated with adding estrogen to the body.




Writing online in Molecular Therapy in July, scientists with UF's McKnight Brain Institute describe how they improved thought processes in female mice bred with the inability to produce estrogen receptor-alpha, a protein apparently necessary for healthy learning and memory.

"We were able to restore function in these animals, not by dosing them with estrogen, but by enabling them to use the estrogen that was naturally present in their bodies," said Tom Foster, Ph.D., the Evelyn F. McKnight chair for brain research in memory loss at the UF College of Medicine. "We discovered that you can affect the estrogen receptor directly in the hippocampus, right where it's needed to address memory and spatial learning."

Changes in the estrogen receptor have been associated with age-related memory deficits and an increased incidence of Alzheimer's disease among women. In addition, previous studies have shown estrogen replacement may improve cognition in postmenopausal women and younger women with low estrogen levels. Estrogen also appears to protect against Alzheimer's disease and dementia.

The downside is that estrogen is a powerful hormone that has far-reaching effects throughout the body. It has been associated with a slight increase in women's risk for breast cancer, heart disease in patients with existing cardiovascular problems, and stroke.

"Estrogen may act as a growth agent for cancer, but in the brain, it appears to maintain health and counteract stress," Foster said. "We wanted to come back and enhance the signaling pathway that makes estrogen functional. We used a gene therapy technique that enables us to target the brain, but ultimately there could be a pharmaceutical that enhances the signaling pathway solely in the brain."

The mice had unusually low levels of estrogen because their ovaries were removed at an early age. However, scientists were still able to rescue learning ability by delivering the correct gene to produce estrogen receptor-alpha directly to the hippocampus.

Mice that lacked the estrogen receptor showed poor ability to locate a platform hidden in a small swimming tank over a training period of several days. After receiving the gene, the mice learned to locate the platform in two days of training.

"This research shows that when the estrogen receptor-alpha is restored to adult mice that have been missing it their entire lives, it is still possible to enhance memory and learning," said John H. Morrison, Ph.D., dean of basic sciences and the Graduate School of Biological Sciences at Mount Sinai School of Medicine, who did not participate in the research. "This is good news for moving forward to develop clinical interventions and therapeutics because it appears critical damage was not done to brain circuitry during early development. There has also been debate about which of at least two estrogen receptors is key to synaptic health. Clearly estrogen receptor-alpha plays a critically important role in hippocampal organization and function."

Recordings made from the brain tissue of treated mice showed signals were strongly communicated across the gaps, or synapses, between hippocampal cells, similar to what would happen with estrogen replacement.

"Investigating the impact of genetically replacing the estrogen receptor at the cellular, synaptic and behavioral levels is a scientific tour de force which provides a strong foundation for the role of estrogen receptor alpha in mediating estrogen action in the hippocampus to restore select types of memory function," said Roberta Diaz Brinton, Ph.D., a professor of pharmacology and pharmaceutical sciences and biomedical engineering at the University of Southern California, who was not involved in the study. "From a technology perspective, their technique to transfect the estrogen receptor is an exciting advance for researching steroid receptors in the brain."

Studying the effects of increasing the estrogen receptor in other brain regions may shed additional light on memory processes.

"The research brings up the idea that local activation of non-nuclear estrogen receptor-alpha is important for regulating memory processes in the hippocampus," said Teresa A. Milner, Ph.D., a professor of neuroscience at Weill Cornell Medical College, who also was also not involved in the research.

University of Florida



Related Estrogen Receptor Current Events and Estrogen Receptor News Articles Estrogen Receptor Current Events and Estrogen Receptor News RSS Estrogen Receptor Current Events and Estrogen Receptor News RSS
Tamoxifen chemoprevention tied to early detection of breast cancer
The drug tamoxifen does not prevent or treat estrogen receptor (ER) negative breast cancer, but it can make the disease easier to find, researchers report in the Oct. 1 Journal of the National Cancer Institute.

New predictive tool can help determine treatment of breast cancer patients
A new predictive measurement, called a PEPI score, could bring good news to many women diagnosed with early stage breast cancer - a low PEPI (preoperative endocrine prognostic index) score could show that they have little risk of relapse and can safely avoid chemotherapy after surgery.

Breast cancer treatment resistance linked to signaling pathway
Activation of the Src signaling pathway may cause resistance to standard medical treatment in some patients with breast cancer, and inhibition of this pathway holds the potential to overcome that resistance, according to data presented here at the American Association for Cancer Research Molecular Diagnostics in Cancer Therapeutic Development meeting.

Risk assessment plays key role in long-term treatment of breast cancer
Breast cancer patients and their physicians may make more informed, long-term treatment decisions using risk assessment strategies to help determine probability of recurrence.

Risk of death after cancer diagnosis; shift in stage of breast cancer diagnosis
Cancer patients with low socioeconomic status (SES) have more advanced cancers at diagnosis, receive less aggressive treatment, and have a higher risk of dying in the five years following cancer diagnosis, according to a new study.

Estrogen Helps Drive Distinct, Aggressive Form of Prostate Cancer
Using a breakthrough technology, researchers led by a Weill Cornell Medical College scientist have pinpointed the hormone estrogen as a key player in about half of all prostate cancers.

Iressa shows promise for treatment of metastatic breast cancer when combined with hormonal therapy
Gefitinib, the once-promising drug formerly approved as a second line treatment for lung cancer, also known as Iressa, enhanced the effectiveness of hormonal therapy for the treatment of specific types of metastatic breast cancer.

Treating osteoporosis calls for physician, dentist collaboration: ADA Journal
Physicians and dentists should collaborate to improve early detection and treatment of patients who have or may develop osteoporosis, say researchers in the cover story of the May issue of The Journal of the American Dental Association.

Previously unseen switch regulates breast cancer response to estrogen
A tiny modification called methylation on estrogen receptors prolongs the life of these growth-driving molecules in breast cancer cells, according to research by scientists at Emory University's Winship Cancer Institute.

Treatment advances for fibroids, menopause
Women with fibroids and endometriosis facing the possibility of hysterectomy may now choose less invasive treatment options to preserve fertility, according to Yale professor Aydin Arici, M.D., who will direct a scientific session exploring these alternatives at the American College of Obstetricians and Gynecologists (ACOG) Annual Clinical Meeting May 3-7 in New Orleans, Louisiana.
More Estrogen Receptor Current Events and Estrogen Receptor News Articles
Belamcanda chinensis and the thereof purified tectorigenin have selective estrogen receptor modulator activities.(research findings): An article from: ... Journal of Phytotherapy & Phytopharmacology
by D. Seidlova-Wuttke, O. Hesse, H. Jarry, G. Rimoldi, P. Thelen, V. Christoffel, W. Wuttke

This digital document is an article from Phytomedicine: International Journal of Phytotherapy & Phytopharmacology, published by Urban & Fischer Verlag on July 1, 2004. The length of the article is 7066 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You...



Selective Estrogen Receptor Modulators: A New Brand of Multitarget Drugs

The experience gained with tamoxifen has been the basis for the new concept of selective estrogen receptor modulators (SERMs). The action of these substances has been investigated in both basic and clinical studies, but there is not an integrated view of all the facets of this recent area in modern medicine. This book offers an up-to-date compilation of the most relevant information on the topic...

A different side of estrogen: second receptor complicates efforts to understand hormone.: An article from: Science News
by Sarah C. Williams

This digital document is an article from Science News, published by Thomson Gale on January 5, 2008. The length of the article is 1972 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation DetailsTitle: A different...

Assessment of xenoestrogens using three distinct estrogen receptors and the zebrafish brain aromatase gene in a highly responsive glial cell system.(Research): ... from: Environmental Health Perspectives
by Yann Le Page, Martin Scholze, Olivier Kah, Farzad Pakdel

This digital document is an article from Environmental Health Perspectives, published by Thomson Gale on May 1, 2006. The length of the article is 7786 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation...



Polyphenols as superoxide dismutase modulators and ligands for estrogen receptors [An article from: Analytica Chimica Acta]
by V. Farines, M.C. Monje, J.P. Telo, E. Hnawia, Sauv

This digital document is a journal article from Analytica Chimica Acta, published by Elsevier in 2004. The article is delivered in HTML format and is available in your Amazon.com Media Library immediately after purchase. You can view it with any web browser.Description: The capacity of estrogen and stilbene derivatives to modulate the activity of superoxide dismutases in relation with their...

Lab reports on estrogen receptors may have 50% false-negative rate. (Ductal Carcinoma in Situ).: An article from: Internal Medicine News

This digital document is an article from Internal Medicine News, published by International Medical News Group on March 1, 2003. The length of the article is 421 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation...

The Estrogen Receptor as a Target for Rational Drug Design (Molecular Biology Intelligence Unit)
by Erwin v. Angerer

This book is about the estrogen receptor as a biochemical target for the design of new agents useful for the therapy and diagnosis of estrogen-related diseases such as carcinomas of the breast, the endometrium, the ovaries and the prostate, osteoporosis, and benign prostate hyperplasia. Some of these drugs have also become valuable tools for investigating the molecular mode of action of estrogens...

Karo Bio patents estrogen receptor complex.(Brief Article): An article from: BIOTECH Patent News

This digital document is an article from BIOTECH Patent News, published by Biotech Patent News on June 1, 2001. The length of the article is 487 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation DetailsTitle:...

Estrogen receptor assays in breast cancer: Laboratory discrepancies and quality assurance



Estrogen modulates place learning through estrogen receptors in the hippocampus [An article from: Neurobiology of Learning and Memory]
by L. Zurkovsky, S.L. Brown, D.L. Korol

This digital document is a journal article from Neurobiology of Learning and Memory, published by Elsevier in 2006. The article is delivered in HTML format and is available in your Amazon.com Media Library immediately after purchase. You can view it with any web browser.Description: Moderate elevations in circulating estradiol enhance learning in tasks that tap place learning strategies such as...

© 2008 BrightSurf.com